Evidence map›Paper›PMID 31213837›Full record

ArticleOncoTargets and therapy2019

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study.

Despoina Kalapanida, Flora Zagouri, Maria Gazouli, Andriani Tsiakou, Eleni Zografos, Constantine Dimitrakakis, Spyridon Marinopoulos, Aris Giannos, Theodoros N Sergentanis, Efstathios Kastritis and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Despoina KalapanidaDepartment of Clinical Therapeutic, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Flora ZagouriDepartment of Clinical Therapeutic, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Maria GazouliDepartment of Basic Medical Sciences, Laboratory of Biology, University of Athens School of Medicine and Laboratory of Cell and Gene Therapy, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Andriani TsiakouFirst Department of Dermatology, Syggros Hospital, University of Athens School of Medicine, Athens, Greece.
Eleni ZografosDepartment of Basic Medical Sciences, Laboratory of Biology, University of Athens School of Medicine and Laboratory of Cell and Gene Therapy, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Constantine DimitrakakisDepartment of Obstetrics and Gynaecology, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Spyridon MarinopoulosDepartment of Obstetrics and Gynaecology, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Aris GiannosDepartment of Obstetrics and Gynaecology, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Theodoros N SergentanisDepartment of Clinical Therapeutic, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Efstathios KastritisDepartment of Clinical Therapeutic, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Evangelos TerposDepartment of Clinical Therapeutic, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
Meletios-Athanassios DimopoulosDepartment of Clinical Therapeutic, Alexandra Hospital, Medical School, University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerMET rs40239MET T1010ISNPStriple-negative breast cancer

Identifiers

PMID31213837
PMCPMC6549390
OpenAlexW2947771083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.